SCHEMBL24090140

SCHEMBL24090140

Cc1ccccc1-n1c(Nc2ccccc2)nc2ccccc2c1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
LMNA P02545 2/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
JUN P05412 2/20 0.64
NFKB1 P19838 2/20 0.64
NFKB2 Q00653 2/20 0.64
RELA Q04206 2/20 0.64
USP2 O75604 1/20 0.59
PDE7A Q13946 1/20 0.57
MAPT P10636 7/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
KDM4E B2RXH2 2/20 0.56
TP53 P04637 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
HTT P42858 2/20 0.55
GAA P10253 1/20 0.55
PKM P14618 1/20 0.55
PDE10A Q9Y233 1/20 0.51
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24089958 0.85 USP2 (0.58) ALDH1A1LMNAL3MBTL1JUNNFKB1
SCHEMBL23064708 0.85 JUN (0.49) ALDH1A1LMNAL3MBTL1JUNNFKB1
SCHEMBL6278052 0.84 MAPT (0.76) ALDH1A1LMNAL3MBTL1JUNNFKB1
SCHEMBL24089968 0.84 USP2 (0.61) ALDH1A1LMNAL3MBTL1JUNNFKB1
Methaqualone SCHEMBL29386732 0.81 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1PDE7AMAPT
Methaqualone SCHEMBL29355239 0.81 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1PDE7AMAPT
Methaqualone SCHEMBL20471677 0.81 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1PDE7AMAPT
Methaqualone SCHEMBL43892 0.81 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1PDE7AMAPT
SCHEMBL24090149 0.80 ALDH1A1 (0.67) ALDH1A1LMNAL3MBTL1JUNNFKB1
Methaqualone SCHEMBL3500629 0.80 ALDH1A1 (0.97) ALDH1A1LMNAL3MBTL1PDE7AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352366-B2 2-aminoquinazolinone derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-06-07 US disclosed
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-05-12 US disclosed
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, CRKL ALDH1A1 645/4885LMNA 2415/4885L3MBTL1 4534/4885
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, SLC26A3 ALDH1A1 739/4885LMNA 2276/4885L3MBTL1 4582/4885
US-11352366-B2 2-aminoquinazolinone derivative CNKSR1, HAX1, SLC26A3 ALDH1A1 739/4885LMNA 2276/4885L3MBTL1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.